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Brief report
CFU-S11 activity does not localize solely with the aorta in the
aorta-gonad-mesonephros region
Marella F. T. R. de Bruijn, Marian C. E. Peeters, Tanya Luteijn, Pim Visser, Nancy A. Speck, and Elaine Dzierzak
The aorta-gonad-mesonephros (AGM) re-
gion is a potent hematopoietic site in the
midgestation mouse conceptus and first
contains colony-forming units–spleen day
11 (CFU-S11) at embryonic day 10 (E10).
Because CFU-S11 activity is present in the
AGM region before the onset of hemato-
poietic stem cell (HSC) activity, CFU-S11
activity in the complex developing vascu-
lar and urogenital regions of the AGM was
localized. From E10 onward, CFU-S11 ac-
tivity is associated with the aortic vascu-
lature, and is found also in the urogenital
ridges (UGRs). Together with data ob-
tained from organ explant cultures, in
which up to a 16-fold increase in CFU-S11
activity was observed, it was determined
that CFU-S11 can be increased autono-
mously both in vascular sites and in
UGRs. Furthermore, CFU-S11 activity is
present in vitelline and umbilical vessels.
This, together with the presence of CFU-S11
in the UGRs 2 days before HSC activity,
suggests both temporally and spatially dis-
tinct emergent sources of CFU-S11. (Blood.
2000;96:2902-2904)
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Introduction
During mouse embryonic development, different hematopoietic
cell types are successively generated at several locations within the
conceptus. At embryonic day 7.5 (E7.5), primitive erythrocytes and
their direct progenitors are found in the yolk sac (YS).1 Shortly
thereafter, the first definitive, in vitro clonable hematopoietic
progenitors are formed in the YS and embryo body.2-4 Cells capable
of in vivo hematopoietic activity are found slightly later in both the
YS and the embryo: at E9 colony-forming units–spleen day 8
(CFU-S8)5 and neonatal repopulating cells6 and at E10 CFU-S115
and adult repopulating cells.7 We previously showed that long-term
adult repopulating hematopoietic stem cells (HSCs) autonomously
emerge first in the intrabody aorta-gonad-mesonephros (AGM)
region (more than 34 somite pair [sp]).8 More recently we
subdissected the AGM region into separate pieces containing either
the aorta and surrounding mesenchyme or urogenital ridges
(UGRs) and demonstrated that adult repopulating HSCs are first
found exclusively in the area of the dorsal aorta and not in the
flanking UGRs.9 B-cell progenitors in E10 AGM were also found
predominantly in the aorta/mesentery subregion.3 However, sublo-
calization has not been performed on CFU-S11, a myeloid-restricted
stem cell subset that is slightly downstream from HSCs in the adult
hematopoietic differentiation hierarchy.
We previously showed that CFU-S11 can be detected in the
AGM region slightly earlier (32-33 sp) than adult repopulating
HSCs (at least 34 sp).7,8 Spatial and temporal mapping of CFU-S11
activity in the AGM should help delineate the relationship between
the functionally distinct CFU-S11 and HSCs and contribute to our
insight into the complex process of the onset of definitive
hematopoiesis. Here we show that unlike HSCs, which are initially
localized to the area of the dorsal aorta, CFU-S11 are found in both
the aorta and UGRs of E10 to E12 embryos. The number of
CFU-S11 in the aorta and in UGRs increases over developmental
time. Furthermore, our data demonstrate that the aorta and UGRs
are capable of autonomously increasing CFU-S11 activity in
explant cultures, suggesting that CFU-S11 are generated in situ
either from direct precursors or from pre-existing HSCs and
expand during the in vitro culture period.
Study design
Embryo generation
C57BL/10 3 CBA F1 female mice were mated with C57BL/10 3 CBA F1
or ln7210 male mice to generate embryos of appropriate ages. The day of
vaginal plug discovery was considered E0. At day 10, 11, or 12 of
pregnancy, the females were killed by cervical dislocation. The mice were
housed according to institutional guidelines, and animal procedures were
carried out in compliance with the standards for Humane Care and Use of
Laboratory Animals.
Cell preparation
The embryos were taken out of the uterus, and AGMs were dissected.11
Subsequently, AGMs were subdissected into the aorta with its surrounding
mesenchyme and the UGRs using 27-gauge insulin syringes (Becton
Dickinson, San Jose, CA). The tissues were either cultured in 3-day explant
cultures8 or directly processed for transplantation into irradiated adult mice.
Cell suspensions of freshly isolated or cultured tissues were obtained by
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collagenase digestion as previously described.11 Viable cells were counted
using trypan blue (Sigma Chemical, St Louis, MO).
CFU-S11 assay
Cell suspensions of AGM, aorta, or UGRs were injected intravenously into
the tail vein of adult (8-14 weeks old) C57BL/10 3 CBA F1 mice (male or
female). The recipients were conditioned by 1000 rads of g-irradiation,
which was administered in a split dose, with 3 hours between doses. The
mice were killed 11 days after transplantation by cervical dislocation. The
spleens were removed and fixed in Tellesniczky’s fixative, and the colonies
were counted by macroscopic observation.
Scanning electron microscopy
Isolated AGMs were fixed in 2.5% glutaraldehyde (Sigma), post-fixed in
1% osmium tetroxide (OsO4), dehydrated in ethanol, and critically point-
dried. The tissues were mounted on stubs, coated with gold/paladium, and
examined with a JEOL (Tokyo, Japan) JSM-25 electron microscope.
Results and discussion
The spatial and temporal distribution of CFU-S11 in the E10 to E12
AGM region was examined after subdissecting this tissue into parts
containing the aorta with its surrounding mesenchyme and the
UGRs. As shown in scanning electron micrographs, the AGM
doubles in size from E10 to E12 (Figure 1A). During this time theFigure 1. Changes in morphology and cell counts of the E10, E11, and E12 AGMregion. (A) Scanning electron micrographs of the E10 (left), E11 (middle), and E12
(right) AGM region in which the excretory and reproductive systems are undergoing
rapid growth and morphogenic changes. A indicates aorta; G, genital ridge/gonad; M,
pro/mesonephros; Mn, metanephros; Me, mesenchyme; and Mt, mesentery (original
magnification 3 40). (B) The ongoing organogenesis results in an increase in the cell
number within the AGM from E10 to E12. Viable cell numbers for the subdissected
aorta, UGRs, and entire AGM after collagenase treatment are given for each
embryonic day (the mean 6 SD). UGRs comprised pro/mesonephroi and genital
ridges/gonads. Cell counts of E12 UGRs were obtained from counts of whole UGRs
(n 5 2) and in part from counts of UGRs further subdissected into pro/mesonephroi
and gonads (n 5 3). At E12 the emerging metanephroi were not included in the cell
counts of the total AGM region or UGRs. After 3 days of organ explant culture, the cell
counts (given as 3 104 cells) for the different tissues were (1) E10: aorta, 5.6; UGRs,
7.1; and AGM, 13.0; (2) E11: aorta, 5.4 6 2.5; UGRs, 8.2 6 1.9; and AGM,
22.0 6 2.7; and (3) E12: aorta, 6.0; UGRs, 18.0; and AGM, 30.8.
Figure 2. Distribution of CFU-S11 in the aorta and UGRs. (A, B) The aorta with
surrounding mesenchyme and the UGRs were dissected from E10 to E12 embryos,
and cell suspensions of these tissues were directly injected into irradiated adult mice
to assay for CFU-S11. (C) Organ explant cultures (3 days) of the subdissected tissues
were performed prior to transplantation. The total number of CFU-S11 per tissue is
given in panel A, the frequency in panel B, and the total number after organ explant
culture in panel C (fold increase compared with uncultured tissues are shown in
parentheses). The data are the mean of results obtained from individually trans-
planted mice in a total of 14 independent experiments. CFU-S11 values (given as
times 104 cells) for the aorta and UGRs ranged from (A) E10: aorta, 0-0.3, and UGRs,
0-0.2; E11: aorta, 0-0.7, and UGRs, 0-0.35; E12: aorta, 0.42-1.0, and UGRs,
0.42-0.75; (B) E10: aorta, 0-4.2, and UGRs, 0-3.17; E11: aorta, 0-5.1, and UGRs,
0-3.2; E12: aorta, 2.8-6.6, and UGRs, 3.2-7.2; and (C) E10: aorta, 0.2-0.71, and
UGRs, 0-0.27; E11: aorta, 0.22-3.14, and UGRs, 1.5-3.33; and E12, aorta 0.67-1.1,
and UGRs, 0.6-0.9. In panels A and C, the number of CFU-S11 per UGRs at E12 was
calculated from the number of CFU-S11 obtained from whole UGRs and partly from
the number obtained from isolated gonads and pro/mesonephroi. The number of
CFU-S11 obtained per embryo equivalent (ee) of whole E12 UGRs was 0.6 in panel A
and 0.75 in panel C; the number obtained from gonads and pro/mesonephroi was 0.1
and 0.4, respectively, in panel A and 0 and 0.7, respectively, in panel C. The
frequency of CFU-S11 (panel B) was calculated from the number of colonies per ee
and the cell counts per tissue. For direct transplantations (panels A and B) the
following total numbers of tissues were injected: E10: both aorta and UGRs, 40 ee;
E11: aorta, 53 ee, and UGRs, 47.5 ee; and E12: aorta, 22 ee; UGRs, 8 ee; gonads, 14
ee; and mesonephroi, 14 ee. For the cultured data (panel C): E10, aorta, 26 ee, and
UGRs, 27 ee; E11: both aorta and UGRs, 22 ee; and E12: aorta, 26 ee; UGRs, 20 ee;
gonad and mesonephri, 6 ee. (D) A summary of the distribution of HSCs in the E10 to
E12 aorta and UGRs is given (from de Bruijn et al9). ND indicates not determined.
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distinctive features of the maturing excretory and reproductive
systems allow for the precise separation of the UGRs from the
dorsal aorta and mesenchyme. Cell counts were performed on the
whole AGM, subdissected aorta, and UGRs. All tissues showed a
2-fold increase in cell number from E10 to E12 (Figure 1B). After
E12, following further organogenesis, the AGM region as such
recedes, and hematopoiesis takes place in the fetal liver.12
CFU-S11 were present in both the area of the aorta and UGRs at
E10, E11, and E12 (Figure 2A). This was in agreement with the
sublocalization of CFU-S8 that was found at E10.13 A significant
increase in CFU-S11 was observed between E10 and E12, ie,
4.8-fold for the aorta and 11.2-fold for the UGRs (P # .003, as
determined by linear regression analysis). At all time points there
were more CFU-S11 in the aorta than in the UGRs (75%, 70%, and
56% of the recovered CFU-S11 for E10, E11, and E12, respec-
tively). Also, the frequency of CFU-S11 was highest in the aorta at
E10 and E11 (Figure 2B). Although the aorta appears to harbor
more CFU-S11 than the UGRs, the precise site of CFU-S11 origin
remains uncertain. Similar to adult repopulating HSCs,9 CFU-S11
may find their origin in association with the intra-embryonic
vasculature. To examine this possibility, we also transplanted cells
of the vitelline and umbilical vessels. At E10.5 and E11, we
found 0.3 and 1.6 CFU-S11, respectively, per embryo equivalent
of transplanted vitelline and umbilical cells, suggesting that
CFU-S11 may be generated and/or expanded in association with
vascular tissue.
The temporal increase in CFU-S11 activity in the aorta and also
in the UGRs may reflect either the autonomous generation and/or
expansion of these cells in the aorta and UGRs or the influx of
CFU-S11 into these tissues. To examine these possibilities, organ
explants of the E10 to E12 aorta and UGRs were cultured prior to
assaying CFU-S11 activity. At E10, CFU-S11 activity was main-
tained during culture (Figure 2C) and at best showed an average
2.5-fold increase compared to directly transplanted cells. In
contrast, CFU-S11 activity significantly increased in cultures of the
E11 aorta (5-fold) and UGRs (16.6-fold) (P , .05 and P , .005,
respectively, as determined by the Mann-Whitney U test). At E12,
CFU-S activity was maintained in these cultured tissues. These
data indicate that both the E11 aorta and UGRs are capable of
significantly increasing CFU-S11 in a manner that is independent of
influx from other embryonic sites. This suggests that the increased
CFU-S11 activity between E11 and E12 (P , .02, as determined by
the t test) reflects in situ generation and/or expansion of CFU-S11.
Interestingly, the culture of E11 UGR explants results in the
greatest increase in CFU-S11 numbers. This result is reminiscent of
the dramatic increase in HSCs in the E11 UGR explant cultures we
recently observed9 and leads us to speculate that this increase in
CFU-S11 results from their differentiation from newly formed
HSCs in the UGR cultures. Indeed, CFU-S11 were found in all the
same sites where the first HSCs were found. However, the
observation that CFU-S11 were detected in the UGRs before HSCs
emerged in this site (Figure 2D) leaves open the question of how
these 2 hematopoietic cell types are related to each other during
early embryogenesis. A possibility is that CFU-S11 and HSCs are
derived separately from different precursors, such as putative
hemangioblasts. This would be in agreement with data showing
multiple sites of hematopoietic birth in avian embryos.14 Thus, the
CFU-S we detected may be derived by 2 different means.
In the present study we report the temporal and spatial
emergence of CFU-S11 activity within the mouse AGM. We show
that from mid-E10 onward, CFU-S11 are increasingly found both in
the area of the aorta and in the UGRs, and that CFU-S11 can be
increased autonomously in both sites. It is of great interest to
further examine the cells and factors involved in the increase of
CFU-S11 activity as well as the possible lineage relationships
between putative hemangioblasts, CFU-S11 and HSCs. Such stud-
ies are likely to provide additional insight in the origin and ex vivo
manipulation of the clinically important HSCs.
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